SCHEMBL23213621

SCHEMBL23213621

NNc1ncc(C(=O)N2CCOCC2)s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.54
HTR2C P28335 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
ALDH1A1 P00352 5/20 0.42
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
PKM P14618 1/20 0.41
RAB9A P51151 1/20 0.41
OGA O60502 1/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
RIPK1 Q13546 1/20 0.40
GRM5 P41594 2/20 0.40
GAA P10253 2/20 0.39
USP2 O75604 1/20 0.39
ALOX15 P16050 1/20 0.39
DUSP3 P51452 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2060505 0.81 HPGD (0.58) HPGDHTR2CL3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL15921792 0.79 HPGD (0.60) HPGDHTR2CL3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL1657049 0.79 HPGD (0.60) HPGDHTR2CL3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL10039298 0.78 HPGD (0.58) HPGDHTR2CL3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL24975813 0.75 HPGD (0.55) HPGDHTR2CL3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL26702865 0.74 HPGD (0.54) HPGDHTR2CL3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL31206782 0.73 HPGD (0.53) HPGDHTR2CL3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL11387823 0.72 HTR2C (0.67) HPGDHTR2CL3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL1660259 0.71 GRM5 (0.78) HPGDHTR2CL3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL22750823 0.71 HCAR2 (0.52) HPGDSMN1; SMN2ALDH1A1NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4041393-B1 NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES BAYER AG (DE) 2026-04-08 EP disclosed
CN-117567338-A Novel heteroaryl triazole compounds as pesticides 拜耳公司 2024-02-20 CN disclosed
US-20230028441-A1 NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES ELANCO ANIMAL HEALTH GMBH (DE) 2023-01-26 US disclosed
US-20230028441-A1 NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES ELANCO ANIMAL HEALTH GMBH (DE) 2023-01-26 US disclosed
EP-4041393-A1 NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES Bayer Aktiengesellschaft (DE) 2022-08-17 EP disclosed
CN-114867529-A Novel heteroaryl triazole compounds as pesticides 拜耳公司 2022-08-05 CN disclosed
WO-2021069567-A1 NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 2021-04-15 WO disclosed
WO-2021069567-A1 NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 2021-04-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230028441-A1 NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES PRXL2A, GLRX3, CYP4F3 HPGD 4450/4885HTR2C 1983/4885L3MBTL1 34/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.